{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T05:03:55Z","timestamp":1780376635405,"version":"3.54.1"},"reference-count":62,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy characterized by poor prognosis and limited therapeutic response. Cancer stem cells (CSCs) contribute to tumor progression, therapeutic resistance, and tumor recurrence. Among transcriptional regulators potentially involved in these processes, Specificity Protein 1 (SP1) has emerged as a candidate integrator of oncogenic and epigenetic signaling networks. However, its contribution to CSC-associated phenotypes and drug resistance in HCC remains incompletely defined. In this study, we combined transcriptomic analyses of TCGA datasets with functional experiments in HCC cell lines (Huh7 and HepG2). SP1-associated transcriptional programs were targeted pharmacologically using mithramycin A (MIT-A) and genetically using siRNA-mediated knockdown. The effects were assessed by RNA sequencing, RT-qPCR, Western blotting, flow cytometry, and functional assays evaluating proliferation, migration, CSC-associated properties, and response to sorafenib. MIT-A treatment markedly reduced the expression of stemness-associated transcription factors (NANOG, OCT4, SOX2) and CSC markers (CD133, CD24), impaired CSC-related functions including ALDH activity and the Side Population phenotype, and inhibited cell proliferation and migration. MIT-A also sensitized both parental and sorafenib-resistant HCC cells to sorafenib, associated with modulation of apoptotic regulators and reduced transporter-mediated efflux activity. SP1 knockdown partially reproduced several of these effects, supporting a contribution of SP1-dependent transcriptional programs to these phenotypes. Overall, these findings identify SP1-associated transcriptional networks as potential regulators of CSC features and therapeutic resistance in HCC and support targeting SP1-associated transcriptional programs as a strategy to enhance sorafenib efficacy.<\/jats:p>","DOI":"10.3390\/cells15110961","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:05:08Z","timestamp":1779721508000},"page":"961","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacological Inhibition of SP1 Reverses Cancer Stemness and Enhances Sorafenib Efficacy in Hepatocellular Carcinoma"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3103-1294","authenticated-orcid":false,"given":"Ma\u00ebl","family":"Padelli","sequence":"first","affiliation":[{"name":"INSERM UMR-S 1193, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"},{"name":"Department of Biochemistry and Oncogenetics, Paul Brousse Hospital, AP-HP, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Desterke","sequence":"additional","affiliation":[{"name":"INSERM UMR1310, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurore","family":"Devocelle","sequence":"additional","affiliation":[{"name":"INSERM UMR-S 1193, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8447-9826","authenticated-orcid":false,"given":"Denis","family":"Clay","sequence":"additional","affiliation":[{"name":"INSERM UMS-44, H\u00f4pital Paul Brousse, Universit\u00e9 Paris-Saclay, 94807 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Bourillon","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Oncogenetics, Paul Brousse Hospital, AP-HP, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Uzan","sequence":"additional","affiliation":[{"name":"INSERM UMR-S 1193, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Lemoine","sequence":"additional","affiliation":[{"name":"INSERM UMR-S 1193, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"},{"name":"Department of Biochemistry and Oncogenetics, Paul Brousse Hospital, AP-HP, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6613-6099","authenticated-orcid":false,"given":"Julien","family":"Giron-Michel","sequence":"additional","affiliation":[{"name":"INSERM UMR-S 1193, Universit\u00e9 Paris-Saclay, 94800 Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1758835918816287","DOI":"10.1177\/1758835918816287","article-title":"Cancer Stem Cells in Hepatocellular Carcinoma: An Overview and Promising Therapeutic Strategies","volume":"10","author":"Wang","year":"2018","journal-title":"Ther. Adv. Med. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/s41416-020-0823-9","article-title":"Cancer Stemness in Hepatocellular Carcinoma: Mechanisms and Translational Potential","volume":"122","author":"Tsui","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"8721","DOI":"10.7150\/thno.41648","article-title":"Stem Cell Programs in Cancer Initiation, Progression, and Therapy Resistance","volume":"10","author":"Huang","year":"2020","journal-title":"Theranostics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40259-024-00702-0","article-title":"State-of-the-Art Liver Cancer Organoids: Modeling Cancer Stem Cell Heterogeneity for Personalized Treatment","volume":"39","author":"Padelli","year":"2025","journal-title":"BioDrugs"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-025-02360-2","article-title":"Cancer Stem Cells: Landscape, Challenges and Emerging Therapeutic Innovations","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Gao, Y., Gan, K., Liu, K., Xu, B., and Chen, M. (2021). SP1 Expression and the Clinicopathological Features of Tumors: A Meta-Analysis and Bioinformatics Analysis. Pathol. Oncol. Res., 27.","DOI":"10.3389\/pore.2021.581998"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/febs.13148","article-title":"Sp1 and the \u2018Hallmarks of Cancer\u2019","volume":"282","author":"Beishline","year":"2015","journal-title":"FEBS J."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pharmthera.2015.05.008","article-title":"Sp1 Transcription Factor: A Long-Standing Target in Cancer Chemotherapy","volume":"152","author":"Mansilla","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Koizume, S., and Miyagi, Y. (2015). Diverse Mechanisms of Sp1-Dependent Transcriptional Regulation Potentially Involved in the Adaptive Response of Cancer Cells to Oxygen-Deficient Conditions. Cancers, 8.","DOI":"10.3390\/cancers8010002"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"114456","DOI":"10.1016\/j.jep.2021.114456","article-title":"Crosstalk of LncRNA HOTAIR and SP1-Mediated Repression of PDK1 Contributes to \u03b2-Elemene-Inhibited Proliferation of Hepatocellular Carcinoma Cells","volume":"283","author":"Wu","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1158\/1055-9965.EPI-07-2791","article-title":"Sp1, a New Biomarker That Identifies a Subset of Aggressive Pancreatic Ductal Adenocarcinoma","volume":"17","author":"Jiang","year":"2008","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_12","first-page":"4126","article-title":"Role of Sp1 Expression in Gastric Cancer: A Meta-Analysis and Bioinformatics Analysis","volume":"18","author":"Shi","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s12253-018-0422-8","article-title":"High-Level Sp1 Is Associated with Proliferation, Invasion, and Poor Prognosis in Astrocytoma","volume":"25","author":"Chen","year":"2019","journal-title":"Pathol. Oncol. Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"15202","DOI":"10.1038\/s41598-019-50917-3","article-title":"Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells","volume":"9","author":"Quarni","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1038\/onc.2012.331","article-title":"Epigenetic Regulation of CD133\/PROM1 Expression in Glioma Stem Cells by Sp1\/Myc and Promoter Methylation","volume":"32","author":"Gopisetty","year":"2013","journal-title":"Oncogene"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s10059-013-0191-x","article-title":"Transcription Factors Sp1 and Sp3 Regulate Expression of Human ABCG2 Gene and Chemoresistance Phenotype","volume":"36","author":"Yang","year":"2013","journal-title":"Mol. Cells"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1007\/s12672-024-01533-9","article-title":"Succinylation Modification-Mediated Upregulation of Sp1 Promotes Hepatocellular Carcinoma Cell Proliferation","volume":"15","author":"Han","year":"2024","journal-title":"Discov. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.7150\/thno.43640","article-title":"Dysregulated Sp1\/miR-130b-3p\/HOXA5 Axis Contributes to Tumor Angiogenesis and Progression of Hepatocellular Carcinoma","volume":"10","author":"Liao","year":"2020","journal-title":"Theranostics"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"101415","DOI":"10.1016\/j.xcrm.2024.101415","article-title":"Disruption of MerTK Increases the Efficacy of Checkpoint Inhibitor by Enhancing Ferroptosis and Immune Response in Hepatocellular Carcinoma","volume":"5","author":"Wang","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1080\/21655979.2021.1947939","article-title":"Transcription Factor Specificity Protein 1-Mediated Serine\/Threonine Kinase 39 Upregulation Promotes the Proliferation, Migration, Invasion and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma Cells by Activating the Transforming Growth Factor-\u03921\/Smad2\/3 Pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e2377","DOI":"10.1038\/cddis.2016.282","article-title":"miR-612 Suppresses Stem Cell-like Property of Hepatocellular Carcinoma Cells by Modulating Sp1\/Nanog Signaling","volume":"7","author":"Liu","year":"2016","journal-title":"Cell Death Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1093\/bib\/bbz174","article-title":"An Absolute Human Stemness Index Associated with Oncogenic Dedifferentiation","volume":"22","author":"Zheng","year":"2021","journal-title":"Brief. Bioinform."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ng.127","article-title":"An Embryonic Stem Cell-like Gene Expression Signature in Poorly Differentiated Aggressive Human Tumors","volume":"40","author":"Thomson","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/gm291","article-title":"Embryonic Stem Cell-Specific Signatures in Cancer: Insights into Genomic Regulatory Networks and Implications for Medicine","volume":"3","author":"Kim","year":"2011","journal-title":"Genome Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1084\/jem.183.4.1797","article-title":"Isolation and Functional Properties of Murine Hematopoietic Stem Cells That Are Replicating in Vivo","volume":"183","author":"Goodell","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1124\/dmd.113.053140","article-title":"Overlapping Substrate and Inhibitor Specificity of Human and Murine ABCG2","volume":"41","author":"Bakhsheshian","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"9262","DOI":"10.3390\/cimb45110580","article-title":"Interaction and Collaboration of SP1, HIF-1, and MYC in Regulating the Expression of Cancer-Related Genes to Further Enhance Anticancer Drug Development","volume":"45","author":"Kimura","year":"2023","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/carcin\/bgs196","article-title":"Hypoxia Upregulates CD147 through a Combined Effect of HIF-1\u03b1 and Sp1 to Promote Glycolysis and Tumor Progression in Epithelial Solid Tumors","volume":"33","author":"Ke","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2174\/1574888X13666180810120012","article-title":"ALDH as a Stem Cell Marker in Solid Tumors","volume":"14","year":"2019","journal-title":"Curr. Stem Cell Res. Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1158\/1541-7786.MCR-08-0035","article-title":"Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations","volume":"6","author":"Ma","year":"2008","journal-title":"Mol. Cancer Res."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Tsochantaridis, I., Brisimis, D., Tsifintaris, M., Anastasiadou, A., Lazos, E., Ermogenous, A., Christou, S., Antonopoulou, N., Panayiotidis, M.I., and Koukourakis, M.I. (2024). Exploring the Role and Pathophysiological Significance of Aldehyde Dehydrogenase 1B1 (ALDH1B1) in Human Lung Adenocarcinoma. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms251910301"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.7150\/jca.41090","article-title":"Overexpression of Epcam and CD133 Correlates with Poor Prognosis in Dual-Phenotype Hepatocellular Carcinoma","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"E10127","DOI":"10.1073\/pnas.1722100115","article-title":"iNOS Promotes CD24+CD133+ Liver Cancer Stem Cell Phenotype through a TACE\/ADAM17-Dependent Notch Signaling Pathway","volume":"115","author":"Wang","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1038\/bjc.2012.145","article-title":"Activation of JNK and High. Expression Level of CD133 Predict a Poor Response to Sorafenib in Hepatocellular Carcinoma","volume":"106","author":"Hagiwara","year":"2012","journal-title":"Br. J. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.canlet.2013.07.021","article-title":"Autophagy Contributes to the Survival of CD133+ Liver Cancer Stem Cells in the Hypoxic and Nutrient-Deprived Tumor Microenvironment","volume":"339","author":"Song","year":"2013","journal-title":"Cancer Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1002\/ijc.24868","article-title":"Cancer Stem\/Progenitor Cells Are Highly Enriched in CD133+CD44+ Population in Hepatocellular Carcinoma","volume":"126","author":"Zhu","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s41065-025-00564-8","article-title":"Cancer Cell Plasticity and Therapeutic Resistance: Mechanisms, Crosstalk, and Translational Perspectives","volume":"162","author":"Ghorbian","year":"2025","journal-title":"Hereditas"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"36266","DOI":"10.18632\/oncotarget.16742","article-title":"MicroRNA-22 Suppresses the Growth, Migration and Invasion of Colorectal Cancer Cells through a Sp1 Negative Feedback Loop","volume":"8","author":"Xia","year":"2017","journal-title":"Oncotarget"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Sun, X., Xiao, C., Wang, X., Wu, S., Yang, Z., Sui, B., and Song, Y. (2024). Role of Post-Translational Modifications of Sp1 in Cancer: State of the Art. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1412461"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13045-019-0841-3","article-title":"MiR-612 Regulates Invadopodia of Hepatocellular Carcinoma by HADHA-Mediated Lipid Reprogramming","volume":"13","author":"Liu","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/bjc.2012.556","article-title":"A Phase-1b Study of Tivantinib (ARQ 197) in Adult Patients with Hepatocellular Carcinoma and Cirrhosis","volume":"108","author":"Santoro","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0378-1119(99)00357-1","article-title":"The Sp-Family of Transcription Factors","volume":"238","author":"Suske","year":"1999","journal-title":"Gene"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1139\/o04-045","article-title":"Gene Regulation by Sp1 and Sp3","volume":"82","author":"Li","year":"2004","journal-title":"Biochem. Cell Biol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"46","DOI":"10.18632\/oncotarget.28169","article-title":"The Androgen Receptor Inhibits Transcription of GPER1 by Preventing Sp1 and Sp3 from Binding to the Promoters in Prostate Cancer Cells","volume":"13","author":"McDermott","year":"2022","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1182\/blood-2014-08-593343","article-title":"Sp1\/Sp3 Transcription Factors Regulate Hallmarks of Megakaryocyte Maturation and Platelet Formation and Function","volume":"125","author":"Meinders","year":"2015","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.28304","article-title":"Up-Regulation of Histone Methyltransferase SETDB1 by Multiple Mechanisms in Hepatocellular Carcinoma Promotes Cancer Metastasis","volume":"63","author":"Wong","year":"2016","journal-title":"Hepatology"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s13402-025-01157-3","article-title":"The Epigenetic Regulator SETDB1 as a Key Component of Cancer Stem Cells and Drug Resistance in Primary Liver Cancer","volume":"49","author":"Padelli","year":"2026","journal-title":"Cell. Oncol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1073\/pnas.0606373103","article-title":"ESET\/SETDB1 Gene Expression and Histone H3 (K9) Trimethylation in Huntington\u2019s Disease","volume":"103","author":"Ryu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5230\/jgc.2022.22.e26","article-title":"Sp1-Induced SETDB1 Overexpression Transcriptionally Inhibits HPGD in a \u03b2-Catenin-Dependent Manner and Promotes the Proliferation and Metastasis of Gastric Cancer","volume":"22","author":"Fan","year":"2022","journal-title":"J. Gastric Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1038\/s41418-018-0095-6","article-title":"Epigenetic Restriction of Hippo Signaling by MORC2 Underlies Stemness of Hepatocellular Carcinoma Cells","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Death Differ."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13046-019-1442-2","article-title":"DNMT3b\/OCT4 Expression Confers Sorafenib Resistance and Poor Prognosis of Hepatocellular Carcinoma through IL-6\/STAT3 Regulation","volume":"38","author":"Lai","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in Advanced Hepatocellular Carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"M\u00f6hring, C., Berger, M., Sadeghlar, F., Zhou, X., Zhou, T., Monin, M.B., Shmanko, K., Welland, S., Sinner, F., and Schwacha-Eipper, B. (2025). Evaluating Sorafenib (SORA-2) as Second-Line Treatment for Unresectable Hepatocellular Carcinoma: A European Retrospective Multicenter Study. Cancers, 17.","DOI":"10.3390\/cancers17060972"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1177\/1756283X15618129","article-title":"Prognostic Significance of Adverse Events in Patients with Hepatocellular Carcinoma Treated with Sorafenib","volume":"9","author":"Granito","year":"2016","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00432-017-2556-6","article-title":"Metronomic Capecitabine as Second-Line Treatment for Hepatocellular Carcinoma after Sorafenib Discontinuation","volume":"144","author":"Trevisani","year":"2018","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1158\/1535-7163.MCT-06-0426","article-title":"Mithramycin A Sensitizes Cancer Cells to TRAIL-Mediated Apoptosis by down-Regulation of XIAP Gene Promoter through Sp1 Sites","volume":"5","author":"Lee","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.trsl.2014.10.011","article-title":"Mithramycin A Sensitizes Therapy-Resistant Breast Cancer Stem Cells toward Genotoxic Drug Doxorubicin","volume":"165","author":"Saha","year":"2015","journal-title":"Transl. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1002\/hep.32079","article-title":"LSD1-Demethylated LINC01134 Confers Oxaliplatin Resistance Through SP1-Induced P62 Transcription in HCC","volume":"74","author":"Ma","year":"2021","journal-title":"Hepatology"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1038\/sj.onc.1210811","article-title":"CD133+ HCC Cancer Stem Cells Confer Chemoresistance by Preferential Expression of the Akt\/PKB Survival Pathway","volume":"27","author":"Ma","year":"2008","journal-title":"Oncogene"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","article-title":"ABC Transporters, Drug Resistance, and Cancer Stem Cells","volume":"14","author":"Dean","year":"2009","journal-title":"J. Mammary Gland. Biol. Neoplasia"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"108672","DOI":"10.1016\/j.pharmthera.2024.108672","article-title":"Mithramycin and Its Analogs: Molecular Features and Antitumor Action","volume":"260","author":"Portugal","year":"2024","journal-title":"Pharmacol. Ther."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1124\/mol.118.114827","article-title":"Severe Hepatotoxicity of Mithramycin Therapy Caused by Altered Expression of Hepatocellular Bile Transporters","volume":"96","author":"Sissung","year":"2019","journal-title":"Mol. Pharmacol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/11\/961\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:11:32Z","timestamp":1780373492000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/11\/961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":62,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cells15110961"],"URL":"https:\/\/doi.org\/10.3390\/cells15110961","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}